Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity
- PMID: 19062317
- DOI: 10.1016/j.immuni.2008.10.009
Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity
Abstract
Steady-state dendritic cells (DCs) maintain peripheral T cell tolerance, whereas mature DCs generate immunity. CD70 is a costimulatory ligand acquired upon DC maturation. To determine its impact on T cell fate, we have generated mice that constitutively express CD70 in conventional DCs (cDCs). In these mice, naive CD4+ and CD8+ T cells spontaneously convert into effector cells. Administration of peptide without adjuvant, which is ordinarily tolerogenic, elicited tumor-eradicating CD8+ T cell responses and robust CD4+ T cell-independent memory. CD70 was also constitutively expressed in cDCs that inducibly present viral epitopes. In this case, tolerance induction was prevented as well. The antigen-presenting DCs generated protective immunity to virus infection and broke a pre-existing state of CD8+ T cell tolerance. Thus, the sole expression of CD70 by otherwise immature cDCs sufficed to convert CD8+ T cell tolerance into immunity, defining the importance of CD27-CD70 interactions at the interface between T cell and DC.
Similar articles
-
Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.Immunology. 2010 May;130(1):137-49. doi: 10.1111/j.1365-2567.2010.03220.x. Epub 2010 Feb 26. Immunology. 2010. PMID: 20201989 Free PMC article.
-
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.Int Immunol. 2009 Aug;21(8):891-904. doi: 10.1093/intimm/dxp056. Epub 2009 Jun 25. Int Immunol. 2009. PMID: 19556308
-
Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.Eur J Immunol. 2009 Sep;39(9):2325-30. doi: 10.1002/eji.200939548. Eur J Immunol. 2009. PMID: 19701895 Review.
-
Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells.Eur J Immunol. 2007 Mar;37(3):716-28. doi: 10.1002/eji.200636824. Eur J Immunol. 2007. PMID: 17295392
-
Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.Hum Immunol. 2009 May;70(5):340-4. doi: 10.1016/j.humimm.2009.03.004. Epub 2009 Mar 9. Hum Immunol. 2009. PMID: 19275918 Review.
Cited by
-
Molecular control of steady-state dendritic cell maturation and immune homeostasis.Annu Rev Immunol. 2013;31:743-91. doi: 10.1146/annurev-immunol-020711-074929. Epub 2013 Jan 17. Annu Rev Immunol. 2013. PMID: 23330953 Free PMC article. Review.
-
Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.Int Rev Cell Mol Biol. 2019;342:1-25. doi: 10.1016/bs.ircmb.2018.07.003. Epub 2018 Aug 20. Int Rev Cell Mol Biol. 2019. PMID: 30635089 Free PMC article. Review.
-
Novel Targets for the Treatment of Melanoma.Curr Oncol Rep. 2019 Nov 6;21(11):97. doi: 10.1007/s11912-019-0849-4. Curr Oncol Rep. 2019. PMID: 31696329 Review.
-
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy.Immune Netw. 2020 Feb 7;20(1):e3. doi: 10.4110/in.2020.20.e3. eCollection 2020 Feb. Immune Netw. 2020. PMID: 32158591 Free PMC article. Review.
-
Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions.Cancer Biother Radiopharm. 2014 May;29(4):153-61. doi: 10.1089/cbr.2013.1578. Epub 2014 Apr 2. Cancer Biother Radiopharm. 2014. PMID: 24693958 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials